• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
reference materials

Medicaid and CHIP Sickle Cell Disease Report, T-MSIS Analytic Files (TAF) 2017

key information

source: Centers for Medicare and Medicaid Services

year: 2021


Sickle cell disease (SCD), the most prevalent lifelong inherited blood disorder in the United States, causes the body to produce red blood cells shaped like crescents or sickles rather than discs. These sickle-shaped blood cells tend to stick to vessel walls leading to blockage and impeding blood flow. When this occurs, oxygen is not delivered to body tissues, which ultimately leads to severe acute and chronic pain episodes known as crises.

SCD impacts all racial and ethnic groups. Of the approximate 100,000 people affected by SCD in the United States, Black and Hispanic populations are disproportionately impacted. While medical advancements, such as newborn screening, penicillin prophylaxis and therapeutics have transitioned SCD from a fatal childhood disease to a chronic condition, long-term health complications (for example, stroke, acute chest syndrome, and chronic end-organ damage) have been associated with increased morbidity and mortality among people with SCD compared to those without.


full text source

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.